Respiratory syncytial virus nonstructural proteins 1 and 2 are crucial pathogenic factors that modulate interferon signaling and Treg cell distribution in mice

Virology

Volumn 485, Issue , 2015, Pages 223-232

  Yang, Pu ^a   Zheng, Junwen ^a   Wang, Shouyi ^a   Liu, Pin ^a   Xie, Meng ^a   Zhao, Dongchi ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Foxp3+ Treg; Innate immune response; Nonstructural proteins; Pathogenic factors; Respiratory syncytial virus

Indexed keywords

BETA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON; MX1 PROTEIN; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; SMALL INTERFERING RNA; VIRAL PROTEIN; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INNATE IMMUNITY; INTERFERON INDUCTION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TISSUE DISTRIBUTION; VIRUS PATHOGENESIS; WEIGHT REDUCTION; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PATHOGENICITY; PATHOLOGY; PLASMID; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIROLOGY;

MURINAE; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INTERFERONS; MICE; PLASMIDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE FACTORS;

EID: 84939804853     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.07.016     Document Type: Article

References (50)

1. Barik S. Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr. Top. Microbiol. Immunol. 2013, 372:173-191.
2. Bitko V., Shulyayeva O., Mazumder B., Musiyenko A., Ramaswamy M., Look D.C., Barik S. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 2007, 81(4):1786-1795.
3. Bossert B., Conzelmann K.K. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 2002, 76(9):4287-4293.
4. Boyapalle S., Wong T., Garay J., Teng M., San J.H., Mohapatra S., Mohapatra S. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One 2012, 7(2):e29386.
5. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Investig. 2000, 106(12):75-81.
6. Collins P.L., Fearns R., Graham B.S. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr. Top. Microbiol. Immunol. 2013, 372:3-38.
7. Cormier S.A., You D., Honnegowda S. The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev. Anti Infect Ther. 2010, 8(12):1371-1380.
8. Dhuban K.B., Kornete M., Mason E.S., Piccirillo C.A. Functional dynamics of Foxp3(+) regulatory T cells in mice and humans. Immunol. Rev. 2014, 259(1):140-158.
9. van Drunen L.D.H.S., Watkiss E.R. Pathogenesis of respiratory syncytial virus. Curr. Opin. Virol. 2012, 2(3):300-305.
10. Durant L.R., Makris S., Voorburg C.M., Loebbermann J., Johansson C., Openshaw P.J. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J. Virol. 2013, 87(20):10946-10954.
11. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4(4):330-336.
12. Fulton R.B., Meyerholz D.K., Varga S.M. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 2010, 185(4):2382-2392.
13. Goswami R., Majumdar T., Dhar J., Chattopadhyay S., Bandyopadhyay S.K., Verbovetskaya V., Sen G.C., Barik S. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res. 2013, 23(8):1025-1042.
14. Gotoh B., Komatsu T., Takeuchi K., Yokoo J. Paramyxovirus accessory proteins as interferon antagonists. Microbiol. Immunol. 2001, 45(12):787-800.
15. Hall, B.M., Tran, G.T., Robinson, C.M., Hodgkinson, S.J., Induction of antigen specific CD4+CD25+Foxp3+T regulatory cells from naïve natural thymic derived T regulatory cells. Int. Immunopharmacol. , in press. http://dx.doi.org/10.1016/j.intimp.2015.03.049.
16. Hashimoto K., Ishibashi K., Ishioka K., Zhao D., Sato M., Ohara S., Abe Y., Kawasaki Y., Sato Y., Yokota S., Fujii N., Peebles R.S., Hosoya M., Suzutani T. RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules. Virology 2009, 391(2):162-170.
17. Hastie M.L., Headlam M.J., Patel N.B., Bukreyev A.A., Buchholz U.J., Dave K.A., Norris E.L., Wright C.L., Spann K.M., Collins P.L., Gorman J.J. The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways. Mol. Cell. Proteom. 2012, 11(5):108-127.
18. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061.
19. Jin H., Zhou H., Cheng X., Tang R., Munoz M., Nguyen N. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 2000, 273(1):210-218.
20. Josefowicz S.Z., Rudensky A. Control of regulatory T Cell lineage commitment and maintenance. Immunity 2009, 30(5):616-625.
21. Josefowicz S.Z., Niec R.E., Kim H.Y., Treuting P., Chinen T., Zheng Y., Umetsu D.T., Rudensky A.Y. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012, 482(7385):395-399.
22. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4(4):337-342.
23. Kong X., Zhang W., Lockey R.F., Auais A., Piedimonte G., Mohapatra S.S. Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet. Vaccines Ther. 2007, 5:4. 10.1186/1479-0556-5-4.
24. Kotelkin A., Belyakov I.M., Yang L., Berzofsky J.A., Collins P.L., Bukreyev A. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-Cell response as a consequence of suppressing the Type I interferon response. J. Virol. 2006, 80(12):5958-5967.
25. Krishnamoorthy N., Khare A., Oriss T.B., Raundhal M., Morse C., Yarlagadda M., Wenzel S.E., Moore M.L., Peebles R.J., Ray A., Ray P. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat. Med. 2012, 18(10):1525-1530.
26. Lan Q., Fan H., Quesniaux V., Ryffel B., Liu Z., Guo Zheng S. Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?. J. Mol. Cell Biol. 2012, 4(1):22-28.
27. Lee D.C., Harker J.A., Tregoning J.S., Atabani S.F., Johansson C., Schwarze J., Openshaw P.J. CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J. Virol. 2010, 84(17):8790-8798.
28. Liesman R.M., Buchholz U.J., Luongo C.L., Yang L., Proia A.D., DeVincenzo J.P., Collins P.L., Pickles R.J. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J. Clin. Investig. 2014, 124(5):2219-2233.
29. Ling Z., Tran K.C., Teng M.N. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 2009, 83(8):3734-3742.
30. Lo M.S., Brazas R.M., Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 2005, 79(14):9315-9319.
31. Mohapatra S.S., Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev. 2008, 21(3):495-504.
32. Munir S., Hillyer P., Le Nouen C., Buchholz U.J., Rabin R.L., Collins P.L., Bukreyev A. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 2011, 7(4):e1001336.
33. Openshaw P.J., Dean G.S., Culley F.J. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr. Infect. Dis. J. 2003, 22(Suppl. 2):S58-S64. (discussion S64-5).
34. Qin L., Peng D., Hu C., Xiang Y., Zhou Y., Tan Y., Qin X. Differentiation of Th subsets inhibited by nonstructural proteins of respiratory syncytial virus is mediated by ubiquitination. PLoS One 2014, 9(7):e101469.
35. Ramaswamy M., Shi L., Varga S.M., Barik S., Behlke M.A., Look D.C. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006, 344(2):328-339.
36. Ruckwardt T.J., Bonaparte K.L., Nason M.C., Graham B.S. Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J. Virol. 2009, 83(7):3019-3028.
37. Schickli J.H., Dubovsky F., Tang R.S. Challenges in developing a pediatric RSV vaccine. Hum. Vaccines 2009, 5(9):582-591.
38. Schlender J., Bossert B., Buchholz U., Conzelmann K.K. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 2000, 74(18):8234-8242.
39. Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000, 161(5):1501-1507.
40. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 2004, 78(8):4363-4369.
41. Spann K.M., Tran K.C., Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 2005, 79(9):5353-5362.
42. Stokes K.L., Chi M.H., Sakamoto K., Newcomb D.C., Currier M.G., Huckabee M.M., Lee S., Goleniewska K., Pretto C., Williams J.V., Hotard A., Sherrill T.P., Peebles R.S., Moore M.L. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 2011, 85(12):5782-5793.
43. Swedan S., Musiyenko A., Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J. Virol. 2009, 83(19):9682-9693.
44. Swedan S., Andrews J., Majumdar T., Musiyenko A., Barik S. Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location. J. Virol. 2011, 85(19):10090-10100.
45. Teng M.N., Whitehead S.S., Bermingham A., St C.M., Elkins W.R., Murphy B.R., Collins P.L. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J. Virol. 2000, 74(19):9317-9321.
46. Webster M.J., Corry J., Teng M.N. The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation. Virology 2014, 449:62-69.
47. Wright P.F., Karron R.A., Madhi S.A., Treanor J.J., King J.C., O'shea A., Ikizler M.R., Zhu Y., Collins P.L., Cutland C., Randolph V.B., Deatly A.M., Hackell J.G., Gruber W.C., Murphy B.R. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J. Infect. Dis. 2006, 193(4):573-581.
48. Xu X., Zheng J., Zheng K., Hou Y., Zhao F., Zhao D. Respiratory syncytial virus NS1 protein degrades STAT2 by inducing SOCS1 expression. Intervirology 2014, 57(2):65-73.
49. Zheng, J., Yang, P., Tang, Y., Pan, Z., Zhao, D., Respiratory syncytial virus nonstructural proteins upregulate SOCS1 and SOCS3 in the different manner from endogenous IFN signaling, J. Immunol. Res. (ID 738547), in press.
50. Zheng J., Yang P., Tang Y., Zhao D. A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response. Virol. Sin. 2015, 30(3):190-199.